Since N Chandrasekaran took over as chairman on February 21, 2017, Tata Group has been trying to resolve pending issues in group companies and pivot their businesses by leveraging technologies, including Artificial Intelligence (AI), data analytics and Cloud computing

The $106-billion Tata Group has already thrived for a century and a half - more than twice the age of the Republic of India

Budget 2021 has re-imagined both spending and borrowing and reposed faith in large-scale infrastructure building and healthcare as well as bold disinvestment to trigger economic growth and consumption cycle in the economy. That's just what the doctor ordered

The Economic Survey 2020/21 suggests that big spends in infrastructure and healthcare should be the government's priority to speed up post-pandemic recovery. Debt, according to the Survey, is not necessarily bad if borrowing more means faster growth

At the core of India's bid to revive the economy lies the question whether the country can spend substantially more on infrastructure building to generate demand. For that, can it borrow much more?

A host of economists have suggested that the government needs to spend more towards the overall economy and infrastructure to create enough demand in the economy. This would finally bring us out of this recession. But where will the government get resources from? Watch the video as Rajeev Dubey, Editor, Business Today explains ways by which the government could raise resources and spend more to finally achieve its targets, in part 2 of the Budget series. Watch: Union Budget: What's working, what's not for India's economy

The economic revival activities in India have started in full swing now. The country has witnessed a spike in the demand for automobiles and consumer durables, with unemployment declining to one-third of what it was at the peak of lockdown. Watch as Rajeev Dubey, Editor, Business Today, explains which sectors have helped the economy, in Business Today's new 'Budget' series. Also Read: Budget 2021: Date, time, sector-wise expectations; everything you need to knowAlso Watch: Budget 2021: Why India can't borrow more

\"Lightening the balance sheet of the government means divestment and monetising their investments. That is the way to go. If you look at it globally, that is how things have worked out,\" says Krishan

P D Vaghela, Chairman, Telecom Regulatory Authority of India (TRAI), spoke about the various use cases of the 5G network and how it was the right time for India to deploy it. In a discussion with Rajeev Dubey, Editor, Business Today, Vaghela shared the importance of 5G use cases and its implementation status in India. He also added that the next generation telecom network will open endless possibilities and opportunities for IOT, M2M based applications, delivering high speed. Watch as he talks about the different 5G use cases in detail. Watch More: Experts discuss ways by which govt could spur growth of the economy

With serendipity of discoveries, its a bigger challenge for organisations to prevent falling back into old ways

DK Joshi, Chief Economist, CRISIL, Nilesh Shah, Managing Director, Kotak Mahindra Asset Management Company, Mukesh Butani, Managing Partner, BMR Legal Advocates,  Prof. Gourav Vallabh, Spokesperson, Indian National Congress,  Gopal Krishna Agarwal, National Spokesperson, BJP on Economic Affairs, spoke about how the government should aim to spur growth. Watch them in conversation with Rajeev Dubey, Editor, Business Today.Also Read: Jobs have moved from high productivity to low productivity sectors: CMIE

D.K. Joshi, Chief Economist, CRISIL, Gopal Krishna Agarwal, National Spokesperson, BJP on Economic Affairs, Gourav Vallabh, Spokesperson, Indian National Congress, and Mukesh Butani, Managing Partner, BMR Legal Advocates discuss the realistic expectations from the upcoming budget, the challenges the FM faces during these pandemic-hit times and what best can be done. Watch them in discussion with Rajeev Dubey, Editor, Business Today.

Nilesh Shah, Group President and Managing director, Kotak Mahindra Asset Management Company, D.K. Joshi, Chief Economist, CRISIL, Gopal Krishna Agarwal, National Spokesperson, BJP on Economic Affairs, Gourav Vallabh, Spokesperson, Indian National Congress, and Mukesh Butani, Managing Partner, BMR Legal Advocates discuss both long and short term strategies the govt should adopt to raise resources in the upcoming budget. Watch them in conversation with Rajeev Dubey, Editor, Business Today.

India's lockdown-struck gross domestic product (GDP) contracted an unprecedented 23.9 per cent, the worst among major economies, during the first quarter of FY21. However, the pent-up demand pushed up consumption, but shrank GDP by 7.5 per cent in the following quarter. With RBI predicting a small growth, in the third and fourth quarters, the current financial year is likely destined to go down in history as India's fifth recession. Watch as Business Today holds a pre-budget discussion with experts from different industries, including D.K. Joshi, Chief Economist, CRISIL; Gopal Krishna Agarwal, National Spokesperson, BJP on Economic Affairs; Prof. Gourav Vallabh, Spokesperson, Indian National Congress; Mukesh Butani, Managing Partner, BMR Legal Advocates; Nilesh Shah, Managing Director, Kotak Mahindra Asset Management Company; and Akhil Gupta, Vice-Chairman, Bharti Enterprises. They offer their  suggestions for economic growth and expectations from the upcoming budget. Also Read: India's industry output contracts 1.9% in November, bucks revival trend

As vaccines get emergency use authorisation, the question remains as to when full vaccine approval might be granted. WHO's Chief Scientist Dr Soumya Swaminathan spoke to Rajeev Dubey, Editor, Business Today about the process to get full vaccine approval. She also explained how COVID-19 vaccine development can have learnings for future vaccines. Watch the video for more.DCGI needs communication strategy on COVID-19 approvals: WHO's Swaminathan

Full authorisation-better known as \"full pre-qualification\"-is a pre-requisite to sell the vaccine in the open market or for mass immunisation of healthy individuals who are not frontline workers

Dr Krishna Ella, Chairman of Bharat Biotech, said that unlike the clinical trials of AstraZeneca vaccine (which has been licensed to Serum Institute of India), Bharat Biotech did not try to suppress the side effects of vaccine by giving paracetamol to the volunteers. He also said that for his company safety came first. Watch him in conversation with Rajeev Dubey, Editor, Business Today.Also Read: China denies entry to WHO team investigating COVID-19 origins

The vaccine produced by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology, Pune, has courted many controversies since it began its first human trials. In this video, Bharat Biotech chief Dr Krishna Ella talks to Business Today Editor, Rajeev Dubey, about vaccine efficacy and why people get suspicious about Indian companies.

The New Year raises new hopes, new expectations, new aspirations - even new anxieties. Finance Minister Nirmala Sitharaman has raised hopes by inviting ideas to spur growth with a promise to deliver \"a Budget like never before\"

Many lessons have been learnt by the healthcare sector during the duration of the pandemic. Speaking to Rajeev Dubey, Editor, Business Today, Dr Krishna Ella, chairman of Bharat Biotech elaborated on the future of healthcare in the country and the lessons that have been learnt. Dr Ella looks forward to a national task force on the pandemic to plug the gaps in healthcare. Watch the video for more.